Testing effectiveness (Phase 2)Ended earlyNCT00837200
What this trial is testing
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Who this might be right for
Non-hodgkins LymphomaHodgkins LymphomaMultiple Myeloma
Milton S. Hershey Medical Center 13